In a model of hypertension and end-organ damage by angiotensin II or high salt induction, deletion of IL-6 failed to prevent the development of hypertension, but attenuated myocardial inflammation and fibrosis, leading to an improvement in cardiac function [23]. This evidence concerns the gene IL6 and hypertensive disorder.